AI CEOs and Scientists Urge Congress to Tighten Screening of Synthetic DNA

Leading executives from OpenAI, DeepMind, Anthropic, Microsoft AI and other AI labs signed a public letter calling on Congress to adopt stricter rules for companies that sell synthetic DNA and RNA. The signatories argue that advances in artificial‑intelligence‑driven gene design could erode long‑standing barriers that have kept bioweapon creation out of reach for most bad actors. They propose mandatory customer and sequence screening to prevent the misuse of genetic material, warning that AI‑generated pathogens could spark a pandemic or cause mass casualties. Lire la suite